FOI 5712-patient treated with certain drugs

Date: 24 September 2019 to 24 September 2022

  1. Does your trust treat Hereditary angioedema HAE? [Yes/No]
  2. In the last 6 months, how many patients with Hereditary angioedema (HAE) have been treated with,
  • Berint
  • Cinryze
  • Firazyr
  • Ruconest
  • Takhzyro
  • Tranexamic acid
  • Other

 

  1. Over the past 6 months, how many patients with persistent / chronic* Immune thrombocytopenia purpura [ITP] have you treated [include all treatments such as steroids, splenectomy, immune globulins, Rituximab and TPOs]?
  2. Over the past 6 months, how many patients with persistent / chronic* Immune thrombocytopenia purpura [ITP] were new to treatment with the following;
  • Eltrombopag [Revolade]
  • Romiplostim [Nplate]

*Patient has ITP for over 6 months and does not respond to standard active treatments

  1. Over the past 6 months, how many patients have you treated with the following conditions and treatments. If None, please state None.

Total patients

Eltrombopag [Revolade]

Romiplostim [Nplate]

Immune thrombocytopenia purpura [ITP]

 

 

 

Chronic hepatitis C virus (HCV) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy

 

 

 

Acquired severe aplastic anaemia (SAA) who were either refractory to prior immunosuppressive therapy or heavily pre-treated and are unsuitable for haematopoietic stem cell transplantation

 

 

 

Chemotherapy induced thrombocytopenia (CIT)

 

 

 

Myelodysplastic syndromes (MDS)

 

 

 

 

 

 

  • Request ID:
    FOI 5712
  • Category:
    Clinical - Drugs
  • Response:

    Response attached